Health Care & Life Sciences » Pharmaceuticals | PKU Healthcare Corp. Ltd.

PKU Healthcare Corp. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,312
2,258
2,000
2,062
2,135
2,302
Cost of Goods Sold (COGS) incl. D&A
1,914
1,865
1,795
1,674
1,584
1,509
Gross Income
398
393
206
388
551
793
SG&A Expense
269
296
391
333
504
717
EBIT
115
52
199
53
47
71
Unusual Expense
1
-
1
-
-
2
Non Operating Income/Expense
4
15
298
7
5
6
Interest Expense
27
79
76
29
8
12
Pretax Income
98
21
40
44
49
73
Income Tax
23
17
22
22
6
20
Equity in Affiliates
-
-
7
10
10
8
Consolidated Net Income
75
38
12
11
33
45
Net Income
78
27
25
13
34
45
Net Income After Extraordinaries
78
27
25
13
34
45
Net Income Available to Common
78
27
25
13
34
45
EPS (Basic)
0.13
0.05
0.04
0.02
0.06
0.08
Basic Shares Outstanding
596
596
596
596
596
596
EPS (Diluted)
0.13
0.05
0.04
0.02
0.06
0.08
Diluted Shares Outstanding
596
596
596
596
596
596
EBITDA
176
165
76
75
72
90
Other Operating Expense
-
14
45
13
1
4
Non-Operating Interest Income
4
10
10
13
6
6
Minority Interest Expense
3
11
13
1
1
-

About PKU Healthcare Corp.

View Profile
Address
9-10/F, Unit 1, Liangjiang Tiandi
Chongqing Chongqing 401121
China
Employees -
Website http://www.pku-hc.com
Updated 07/08/2019
PKU Healthcare Corp., Ltd. engages in the manufacture, export, research and development of integrated pharmaceutical products. Its products include antipyretic and analgesic capsules; anti tumor capsules, blood sugar control tablets, digestive sticks; cardiovascular capsule, tablets and injections; anti-microbial capsules and other drug products. The company was founded on May 18, 1993 and is headquartered in Chongqing, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.